Q85.02 Neurofibromatosis, type 2

Name of the Condition

• Neurofibromatosis, type 2

Summary

Neurofibromatosis type 2 (NF2) is a genetic disorder characterized by the development of noncancerous tumors, primarily schwannomas, along nerves in the central nervous system. These tumors often affect the vestibular nerves, leading to hearing loss and balance issues, and may also involve other cranial or spinal nerves. The condition can result in a range of neurological symptoms depending on tumor location and size.

Causes

NF2 is caused by mutations in the NF2 gene, which regulates cell growth and nerve development. The condition is typically inherited in an autosomal dominant pattern, meaning a single mutated gene from a parent can cause the disorder. Spontaneous mutations may also occur without a family history.

Risk Factors

• Genetic Inheritance: A family history of NF2 increases the risk of developing the condition.
• Spontaneous Mutations: New genetic mutations can arise even without a family history, contributing to cases.

Symptoms

• Bilateral vestibular schwannomas (tumors on the hearing and balance nerves)
• Hearing loss, often gradual or sudden
• Tinnitus (ringing in the ears)
• Balance problems or dizziness
• Facial weakness or numbness
• Cataracts or other eye abnormalities
• Schwannomas on other cranial or spinal nerves

Diagnosis

Diagnosis involves a clinical evaluation of symptoms, particularly hearing and balance issues, combined with imaging studies such as MRI to detect tumors. Genetic testing may confirm mutations in the NF2 gene, especially in cases with a family history or unclear presentation.

Treatment Options

• Surgical removal of tumors: May be considered to relieve symptoms or prevent complications, depending on tumor size and location.
• Radiation therapy: Used to control tumor growth in some cases.
• Hearing aids or cochlear implants: For managing hearing loss.
• Monitoring: Regular imaging and clinical assessments to track tumor progression.

Prognosis and Follow-Up

Prognosis varies based on tumor location and treatment response. Early diagnosis and management can help preserve hearing and neurological function. Lifelong follow-up is typically recommended to monitor for new or growing tumors and address symptoms as they arise.

Complications

• Progressive hearing loss or deafness
• Facial nerve damage leading to weakness or paralysis
• Vision problems from optic nerve involvement
• Spinal cord compression from spinal tumors
• Increased risk of other nervous system tumors

Lifestyle & Prevention

• Regular medical check-ups to monitor for new symptoms or tumor growth.
• Avoiding activities that may worsen balance issues or increase fall risk.
• Genetic counseling for individuals with a family history to discuss inheritance and testing options.

When to Seek Professional Help

Seek medical attention if you experience sudden hearing loss, persistent balance problems, new neurological symptoms (e.g., facial weakness), or unexplained lumps near nerves. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Document the presence of bilateral vestibular schwannomas, other cranial or spinal nerve tumors, and associated symptoms (e.g., hearing loss, balance issues) to support the diagnosis. Include details of genetic testing or imaging results when available, as these may confirm the condition. Ensure documentation aligns with clinical findings to accurately reflect the complexity of NF2.